News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Wuhan Institute of Biological Products and Refine Technology Collaborate on Vaccines


7/23/2012 10:24:42 AM

by Richard Daverman, PhD

July 20, 2012 -- The Wuhan Institute of Biological Products (WIBF) formed a collaboration with Refine Technology, a US maker of biological manufacturing equipment. WIBF is a division of China National Biological Group, a Sinopharm subsidiary. WIPF and Refine will use Refine’s ATF™ System, a cell retention device, to improve the yield and reduce the cost of vaccine manufacturing. The collaboration will work on a specific novel vaccine, which was not identified. More details....


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES